top of page
Victor, Lietao Li
Founder & CEO of Zeno Therapeutics
Dr. Li is dedicated to translating "first-in-class" immunotherapies to address critical unmet medical needs through various ventures. Before founding BioIP Holdings (managing Eximmium and Zeno Therapeutics), he co-founded Pika NewBiomed (merged into Yisheng Biopharma, NASDAQ: "LSB") and served as the founding CEO of Lion TCR, SCG Cell Therapy, BioSyngen, and BioCheetah. The founding products of these companies are now advancing at various stages of clinical development, including Phase III, II, and I trial.



Speakers
bottom of page